Showing results (61-70 of 163) with videos related to
Sort By:
Pageof 17
Hepatology Communications|December 11, 2020
Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver CirrhosisMasashi Hirooka, Yohei Koizumi, Takaaki Tanaka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 17, 2021
Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosisHironori Ochi, Joji Tani, Tetsu Tomonari, et al.Internal Medicine (Tokyo, Japan)|May 17, 2013
Portal biliopathy diagnosed using color Doppler and contrast-enhanced ultrasoundHiroaki Nunoi, Masashi Hirooka, Hironori Ochi, et al.Internal Medicine (Tokyo, Japan)|May 24, 2019
Schistosomiasis Diagnosed Using Laparoscopy and ColonoscopyYohei Koizumi, Masashi Hirooka, Takaaki Tanaka, et al.Journal of Gastroenterology and Hepatology|July 19, 2019
Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver diseaseMasashi Hirooka, Hironori Ochi, Atsushi Hiraoka, et al.Hepatology International|July 23, 2015
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patientsTakao Watanabe, Yoshio Tokumoto, Kouji Joko, et al.Molecular and Clinical Oncology|July 24, 2014
18F-FDG-PET/CT predicts the distribution of microsatellite lesions in hepatocellular carcinomaHironori Ochi, Masashi Hirooka, Atsushi Hiraoka, et al.Endocrine Journal|May 31, 2019
Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinomaYohei Koizumi, Masashi Hirooka, Atsushi Hiraoka, et al.Journal of Gastroenterology|December 5, 2020
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteriaHironori Ochi, Atsushi Hiraoka, Masashi Hirooka, et al.Oncology Reports|January 1, 2010
Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume systemAtsushi Hiraoka, Masashi Hirooka, Yohei Koizumi, et al.Pageof 17